Drug Targets

Conferences & Courses
Biomarker World Congress Biomarker World Congress
April 30 - May 2, 2014 | Philadelphia, PA
The signature event/conference in Cambridge Healthtech Institute' s Biomarker Series, The Biomarker World Congress/conference 2013 is dedicated to all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline.

Mastering Medicinal Chemistry Mastering Medicinal Chemistry
May 21-22, 2014 | Boston, MA
Mastering Medicinal Chemistry Conference Senior executives and industry thought leaders from Pfizer, Roche, Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, AbbVie, AstraZeneca and many more will participate in this year' s program with inspiring discussio

Structure-Based Drug Design Structure-Based Drug Design
May 21-22, 2014 | Boston, MA
CHI and Bio-IT World Present the Fourteenth Annual Structure-Based Drug Design: Using Structure and Rational Design to Accelerate Discovery conference, May 21-22, 2014, Boston, MA, will showcase informative, high-quality case studies, innovative technique




Life Science Media Library
Allosteric Modulators of GPCRs Allosteric Modulators of GPCRs
September 23, 2013 |
The advancing technology of high-throughput screening is changing the type of molecules found. With protein function more physiologically relevant, the quality of the molecules that pharmacologists and medicinal chemists must deal with is changing. This course will familiarize researchers with the tools needed to exploit this potentially fruitful area of new drug discovery through discussion of allosteric molecules, detection of allosterism, and quantifying allosterism for chemical lead optimization.
Pharmacology and Drug Discovery in the Allosteric World Pharmacology and Drug Discovery in the Allosteric World
November 3, 2011 |
The advancing technology of high-throughput screening is changing the type of molecules found. With protein function more physiologically relevant, the quality of the molecules that pharmacologists and medicinal chemists must deal with is changing. This course will familiarize researchers with the tools needed to exploit this potentially fruitful area of new drug discovery through discussion of allosteric molecules, detection of allosterism, and quantifying allosterism for chemical lead optimization.
Targeting Cancer Stem Cells Targeting Cancer Stem Cells
November 3, 2011 |
Cancer stem cells (CSCs) have been identified in several types of cancer, and may play a role in tumorigenic growth, metastasis, and therapeutic resistance. New anticancer therapeutics are being developed that will inhibit tumor growth and reduce tumor-initiating cell frequency, improving clinical cancer therapy. The development of new agents that block key CSC pathways will be described, as well as a novel assay for tracking CSCs in cell populations without the need to isolate them, and a CSC screening strategy for discovering therapeutic antibodies.




Publications, Reports, & Whitepapers
MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics
This report analyzes recent trends in medicinal chemistry and evaluates their significance for advancing R&D productivity. We consider technological modalities and market dynamics, with an emphasis on outsourcing and user views on the implications of current practices.
Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective
Epigenetics: Emerging Targets, Available Technologies, Expert Interviews, and an Epigenetic Community Perspective provides an overview of the scientific and technological landscape from which both the diagnostic and therapeutic sectors of the nascent epigenetics industry are emerging, plus a qualitative analysis of the scientific, technological, and commercial achievements and challenges facing both sectors.